PET/CT with prostate-specific membrane antigen (PSMA) is an undeniable tool to detect recurrence in PC and it has demonstrated to have strong potential in detecting recurrence or residual disease after brachytherapy and HIFU treatments [8]. Here, FOLH1 is linked to pachyonychia congenita.